MedPath

on invasive imaging of [18F]HX4 with Positron-Emission-Tomography (PET) in Head and Neck Cancer.

Phase 2
Completed
Conditions
Cancer of the Head and Neck
Squamous cell carcinomas of head and neck
10027655
Registration Number
NL-OMON39184
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

- Histological or cytological confirmed HNSSC of the oral cavity, oropharynx, hypopharynx, larynx, T2-T3-T4, any N, M0;- Tumor (or lymph node) diameter * 2,5 cm;- WHO performance status 0 to 2;- Scheduled for primary curative (concurrent chemo-) radiotherapy;- No previous surgery to the head and neck;- No previous radiation to the head and neck;- Adequate renal function (calculated creatinine clearance at least 60 ml/min) ;- The patient is willing and capable to comply with study procedures;- 18 years or older;- Have given written informed consent before patien registration

Exclusion Criteria

No recent (< 3 months) myocardial infarction;- No Uncontrolled infectious disease;- Not pregnant or breast feeding and willing to take adequate contraceptive measures during the study

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Visualisation of tumor hypoxia with [18F] HX4 PET imaging</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath